APA

Moreno-Montañés J., Sádaba B., Ruz V., Gómez-Guiu A., Zarranz J., González M. V., Pañeda C. & Jimenez A. I. (20140813). Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Moreno-Montañés Javier, Sádaba Belén, Ruz Verónica, Gómez-Guiu Almudena, Zarranz Javier, González María Victoria, Pañeda Covadonga and Jimenez Ana Isabel. 20140813. Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Moreno-Montañés J., Sádaba B., Ruz V., Gómez-Guiu A., Zarranz J., González M. V., Pañeda C. and Jimenez A. I. (20140813). Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Moreno-Montañés Javier, Sádaba Belén, Ruz Verónica, Gómez-Guiu Almudena, Zarranz Javier, González María Victoria, Pañeda Covadonga and Jimenez Ana Isabel. Phase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. : Molecular therapy : the journal of the American Society of Gene Therapy. 20140813.